Skip to Main Content

Author Details

David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
1981
404
60
PMIDPaper TitleJournal TitlePublished Year
38043052Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study.Cytotherapy2024
38043052Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study.Cytotherapy2024
37797720Liquid Storage of Peripheral Blood Stem Cell Products: Effects of Time and Temperature on Product Quality.Transplant Cell Ther2024
37797720Liquid Storage of Peripheral Blood Stem Cell Products: Effects of Time and Temperature on Product Quality.Transplant Cell Ther2024
36710226Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.Cytotherapy2023
37714150Building smart CAR T cell therapies: The path to overcome current challenges.Cancer Cell2023
37686058The Potential Use of THP-1, a Monocytic Leukemia Cell Line, to Predict Immune-Suppressive Potency of Human Bone-Marrow Stromal Cells (BMSCs) In Vitro: A Pilot Study.Int J Mol Sci2023
37159663Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells.Cell Rep Methods2023
36647676Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.Clin Cancer Res2023
36710226Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.Cytotherapy2023
37394115Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.Transplant Cell Ther2023
36935289Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays.Cytotherapy2023
36975826Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.Transfusion2023
37714150Building smart CAR T cell therapies: The path to overcome current challenges.Cancer Cell2023
37686058The Potential Use of THP-1, a Monocytic Leukemia Cell Line, to Predict Immune-Suppressive Potency of Human Bone-Marrow Stromal Cells (BMSCs) In Vitro: A Pilot Study.Int J Mol Sci2023
37394115Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.Transplant Cell Ther2023
37159663Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells.Cell Rep Methods2023
36975826Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.Transfusion2023
36647676Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.Clin Cancer Res2023
36935289Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays.Cytotherapy2023
35033098Point-of-care cell therapy manufacturing; it's not for everyone.J Transl Med2022
35770742Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study.Transfusion2022
35902861Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases.J Transl Med2022
36348415Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products.J Transl Med2022
35737751Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.Br J Haematol2022
35486592Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.Int Rev Immunol2022
35605184CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.Blood2022
35534047Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.J Immunother Cancer2022
35468789The need for uniform and coordinated practices involving centrally manufactured cell therapies.J Transl Med2022
36510222Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors.J Transl Med2022
36620075Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells.Mol Ther Methods Clin Dev2022
35033098Point-of-care cell therapy manufacturing; it's not for everyone.J Transl Med2022
35181722Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy.Sci Rep2022
35770742Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study.Transfusion2022
35737751Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.Br J Haematol2022
35468789The need for uniform and coordinated practices involving centrally manufactured cell therapies.J Transl Med2022
35605184CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.Blood2022
35534047Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.J Immunother Cancer2022
35486592Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.Int Rev Immunol2022
36620075Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells.Mol Ther Methods Clin Dev2022
36510222Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors.J Transl Med2022
35902861Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases.J Transl Med2022
36348415Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products.J Transl Med2022
35181722Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy.Sci Rep2022
33232788Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.Cancer Lett2021
33632869Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells.Mol Cancer Ther2021
33956057Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease.Blood Adv2021
33472742Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy.Transfus Apher Sci2021
33731459A link between IL-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.J Virol2021
33993466Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.Br J Haematol2021
  • 1 - 50 of 808

Recommended Authors

Justin E Juskewitch
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Christopher A Tormey
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 1
Jeanne E Hendrickson
Center for Transfusion and Cellular Therapy, Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Philip J Norris
Vitalant Research Institute
Career Start Year 2001
Number of shared co-authors 6
Monique P Gelderman
Center for Biologics Evaluation and Research
Career Start Year 1996
Number of shared co-authors 3
Suzanne M Vercauteren
Clinical Immunology Lab, BC Children's Hospital
Career Start Year 1996
Number of shared co-authors 1
James C Zimring
University of Virginia
Career Start Year 1995
Number of shared co-authors 5
Chance John Luckey
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 2
Gabrielle Meyers
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 2
Jeffrey L Winters
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 5
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Claudia S Cohn
University of Minnesota
Career Start Year 1990
Number of shared co-authors 9
Peter W Marks
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 5
Brenda J Grossman
Washington University School of Medicine
Career Start Year 1988
Number of shared co-authors 3
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 3
Henry M Rinder
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Joanne Kurtzberg
Marcus Center for Cellular Cures, Duke University School of Medicine
Career Start Year 1983
Number of shared co-authors 6
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 5
Steven L Spitalnik
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 1982
Number of shared co-authors 6
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 1
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 2
Brian R Smith
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 0
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 6
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 9
Neil Blumberg
University of Rochester Medical Center
Career Start Year 1974
Number of shared co-authors 1
Paul M Ness
Johns Hopkins University
Career Start Year 1974
Number of shared co-authors 10
Hilary S Warren
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 2
Nancy Rebecca Haley
University of Washington
Career Start Year 1973
Number of shared co-authors 3
Ronald G Strauss
University of Iowa Carver College of Medicine
Career Start Year 1969
Number of shared co-authors 4
Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1958
Number of shared co-authors 3

Collaborators

Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Co-authored papers 61
Harvey G Klein
Clinical Center, National Institutes of Health
Co-authored papers 18
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 12
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 7
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 7
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Sawa Ito
University of Pittsburgh
Co-authored papers 6
Frances T Hakim
National Cancer Institute
Co-authored papers 6
Huan Wang
Clinical Center, National Institutes of Health
Co-authored papers 6
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Co-authored papers 6
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 5
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 5
Masaki Terabe
National Cancer Institute
Co-authored papers 5
John M Kirkwood
UPMC Hillman Cancer Center
Co-authored papers 5
Jeremy J Rose
National Cancer Institute
Co-authored papers 5
David C Halverson
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Jinguo Chen
Center for Human Immunology
Co-authored papers 4
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Neal S Young
National Heart Lung and Blood Institute Division of Intramural Research
Co-authored papers 4
Dale E Hammerschmidt
University of Minnesota
Co-authored papers 4
Magali J Fontaine
University of Maryland School of Medicine
Co-authored papers 4
Reinhard Dummer
University Hospital Zurich
Co-authored papers 3
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Co-authored papers 3
Sandra Demaria
Weill Cornell Medical College
Co-authored papers 3
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Release 1.2